-transparent.png){kind=logo}
Copolymers composed of polar and nonpolar blocks, when blended with a base polymer in low concentrations, migrate to the base polymer surface during and after fabrication. Migration of these surface modifying additives (SMAs) dramatically changes the outermost surface molecular layers that comprise the region that determines biocompatibility. The blood compatibility of cardiopulmonary bypass and hemodialysis components have been improved by using SMA blended polymers or SMA coated surfaces. The particular SMAs used were a series of triblock copolymers with a general formulation of polycaprolactone-polydimethylsiloxane-polycaprolactone. X-ray fluorescence (XRF), fourier transform infrared (FTIR), refractive increments (RI), and gel permeation chromatography (GPC) were used to characterize the molecular weight of SMA and the bulk concentration of SMA after blending. Electron spectroscopy for chemical analysis (ESCA) proved that the surface of blended polymers was highly saturated with SMA. Results of in vitro experiments with human blood demonstrated that SMA blended polymers delay contact activation (kallikrein-like activity), reduce coagulation activity (thrombin-antithrombin [TAT] generation), and do not adversely affect complement activation (terminal complement complex [TCC] generation) or mononuclear cells activation (IL-1 beta production). Ex vivo canine AV shunt studies showed improvement of platelet compatibility of SMA blended polymers. Reduction of cellular and protein system activation by using components fabricated with SMA blood contacting surfaces can potentially result in reduced morbidity associated with extracorporeal circulation.
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
May 1998,
The Annals of thoracic surgery,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
December 1988,
Artificial organs,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
March 1968,
Journal of biomedical materials research,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
March 2003,
Perfusion,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
October 2009,
Small (Weinheim an der Bergstrasse, Germany),
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
February 2022,
Tissue engineering and regenerative medicine,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
December 2012,
Colloids and surfaces. B, Biointerfaces,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
July 1953,
Klinicheskaia meditsina,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
October 2004,
Current medicinal chemistry. Cardiovascular and hematological agents,
C C Tsai, and
R M Deppisch, and
L J Forrestal, and
G H Ritzau, and
A D Oram, and
H J Göhl, and
M E Voorhees
November 1996,
Journal of biomedical materials research,
